Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

614 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Similar efficacy and safety of enteric-coated mycophenolate sodium (EC-MPS, myfortic) compared with mycophenolate mofetil (MMF) in de novo heart transplant recipients: results of a 12-month, single-blind, randomized, parallel-group, multicenter study.
Kobashigawa JA, Renlund DG, Gerosa G, Almenar L, Eisen HJ, Keogh AM, Lehmkuhl HB, Livi U, Ross H, Segovia J, Yonan N; ERL2401 Heart Study Investigators. Kobashigawa JA, et al. Among authors: segovia j. J Heart Lung Transplant. 2006 Aug;25(8):935-41. doi: 10.1016/j.healun.2006.04.005. Epub 2006 Jun 27. J Heart Lung Transplant. 2006. PMID: 16890114 Clinical Trial.
Clinical recommendations for the use of everolimus in heart transplantation.
Manito N, Delgado JF, Crespo-Leiro MG, González-Vílchez F, Almenar L, Arizón JM, Díaz B, Fernández-Yáñez J, Mirabet S, Palomo J, Rodríguez Lambert JL, Roig E, Segovia J. Manito N, et al. Among authors: segovia j. Transplant Rev (Orlando). 2010 Jul;24(3):129-42. doi: 10.1016/j.trre.2010.01.005. Transplant Rev (Orlando). 2010. PMID: 20619801 Review.
Report from a consensus conference on primary graft dysfunction after cardiac transplantation.
Kobashigawa J, Zuckermann A, Macdonald P, Leprince P, Esmailian F, Luu M, Mancini D, Patel J, Razi R, Reichenspurner H, Russell S, Segovia J, Smedira N, Stehlik J, Wagner F; Consensus Conference participants. Kobashigawa J, et al. Among authors: segovia j. J Heart Lung Transplant. 2014 Apr;33(4):327-40. doi: 10.1016/j.healun.2014.02.027. Epub 2014 Mar 5. J Heart Lung Transplant. 2014. PMID: 24661451
The use of proliferation signal inhibitors in the prevention and treatment of allograft vasculopathy in heart transplantation.
Delgado JF, Manito N, Segovia J, Almenar L, Arizón JM, Campreciós M, Crespo-Leiro MG, Díaz B, González-Vílchez F, Mirabet S, Palomo J, Roig E, de la Torre JM. Delgado JF, et al. Among authors: segovia j. Transplant Rev (Orlando). 2009 Apr;23(2):69-79. doi: 10.1016/j.trre.2009.01.002. Transplant Rev (Orlando). 2009. PMID: 19298938 Review.
Report from a consensus conference on antibody-mediated rejection in heart transplantation.
Kobashigawa J, Crespo-Leiro MG, Ensminger SM, Reichenspurner H, Angelini A, Berry G, Burke M, Czer L, Hiemann N, Kfoury AG, Mancini D, Mohacsi P, Patel J, Pereira N, Platt JL, Reed EF, Reinsmoen N, Rodriguez ER, Rose ML, Russell SD, Starling R, Suciu-Foca N, Tallaj J, Taylor DO, Van Bakel A, West L, Zeevi A, Zuckermann A; Consensus Conference Participants. Kobashigawa J, et al. J Heart Lung Transplant. 2011 Mar;30(3):252-69. doi: 10.1016/j.healun.2010.11.003. J Heart Lung Transplant. 2011. PMID: 21300295 Free PMC article.
Rejection after conversion to a proliferation signal inhibitor in chronic heart transplantation.
González-Vílchez F, Vázquez de Prada JA, Paniagua MJ, Almenar L, Mirabet S, Gómez-Bueno M, Díaz-Molina B, Arizón JM, Delgado J, Pérez-Villa F, Crespo-Leiro MG, Martínez-Dolz L, Roig E, Segovia J, Lambert JL, Lopez-Granados A, Escribano P, Farrero M. González-Vílchez F, et al. Among authors: segovia j. Clin Transplant. 2013 Nov-Dec;27(6):E649-58. doi: 10.1111/ctr.12241. Epub 2013 Sep 12. Clin Transplant. 2013. PMID: 24025040
Withdrawal of proliferation signal inhibitors due to adverse events in the maintenance phase of heart transplantation.
Gonzalez-Vilchez F, Vazquez de Prada JA, Almenar L, Arizon Del Prado JM, Mirabet S, Diaz-Molina B, Delgado JF, Gomez-Bueno M, Paniagua MJ, Perez-Villa F, Roig E, Martínez-Dolz L, Brossa V, Lambert JL, Segovia J, Crespo-Leiro MG, Ruiz-Cano MJ. Gonzalez-Vilchez F, et al. Among authors: segovia j. J Heart Lung Transplant. 2012 Mar;31(3):288-95. doi: 10.1016/j.healun.2011.10.011. Epub 2011 Dec 1. J Heart Lung Transplant. 2012. PMID: 22133787
Impact of dose reductions on efficacy outcome in heart transplant patients receiving enteric-coated mycophenolate sodium or mycophenolate mofetil at 12 months post-transplantation.
Segovia J, Gerosa G, Almenar L, Livi U, Viganò M, Arizón JM, Yonan N, Di Salvo TG, Renlund DG, Kobashigawa JA; ERL 2401 Study Group. Segovia J, et al. Clin Transplant. 2008 Nov-Dec;22(6):809-14. doi: 10.1111/j.1399-0012.2008.00887.x. Epub 2008 Aug 12. Clin Transplant. 2008. PMID: 18702660 Clinical Trial.
614 results